Our study demonstrated that the T/T-genotype correlates with elevated TGF-β1 circulating levels in patients with brain cancers compared to the carriers of the other two genotypes (p = 0.023) and compared to the controls (p = 0.011). Here, TGFB1 is linked to brain cancer.